ConductScience.org, home

Paper55652

Immunostimulant therapy with levamisole for rheumatoid arthritis.

Huskisson EC and 5 others. Lancet, 1976. Cited by 187 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Immunostimulant therapy with levamisole for rheumatoid arthritis. Papers, record 55652. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/55652

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Immunostimulant therapy with levamisole for rheumatoid arthritis.
PubMed
Journal
Lancet
PubMed
Year
1976
PubMed
Publication types
Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article
PubMed
Citations, by iCite
187
iCite
Relative citation ratio, by iCite
9.36
iCite
Revised in PubMed
2022-03-16
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Huskisson ECE C
2Scott JJ
3Balme HWH W
4Dieppe PAP A
5Trapnell JJ
6Willoughby DAD A

Source PubMed

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Arthritis, RheumatoidMajor topic
Immunity, CellularMajor topic
LevamisoleMajor topic
Animals
Cell Migration Inhibition
Clinical Trials as Topic
Complement System Proteins
Drug Evaluation
Follow-Up Studies
Humans
Hypersensitivity, Delayed
Immunoglobulins
Male
Mice
Pain
Penicillamine
Placebos
Rats
Skin Tests
Time Factors

Source PubMed

Cited by45

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 187 citations.

PMIDTitleJournalYearIn PapersSource
39,845,058Levamisole, as a viral vaccine adjuvant, induces robust host defense through the modulation of innate and adaptive immune responses.Front Microbiol2024https://conductscience.org/library/papers/39845058PubMed
39,598,415Levamisole Ameliorates Rheumatoid Arthritis by Downregulating the PI3K/Akt Pathway in SD Rats.Pharmaceuticals (Basel)2024https://conductscience.org/library/papers/39598415PubMed
32,762,741Standardized ethanol extract of Tinospora crispa upregulates pro-inflammatory mediators release in LPS-primed U937 human macrophages through stimulation of MAPK, NF-κB and PI3K-Akt signaling networks.BMC Complement Med Ther2020https://conductscience.org/library/papers/32762741PubMed
29,628,691Prospective study of immunomodulation in osteoarticular tuberculosis non responsive to anti tubercular therapy.J Clin Orthop Trauma2018https://conductscience.org/library/papers/29628691PubMed
16,259,711Derek Willoughby: an appreciation from a clinical rheumatologist.Inflammopharmacology2005https://conductscience.org/library/papers/16259711PubMed
16,259,705Professor Derek Albert Willoughby (1930-2004).Inflammopharmacology2005https://conductscience.org/library/papers/16259705PubMed
10,796,440Penicillamine for rheumatoid arthritis.Cochrane Database Syst Rev2000https://conductscience.org/library/papers/10796440PubMed
7,166,176Pharmacokinetics of levamisole in healthy subjects and cancer patients.Eur J Drug Metab Pharmacokinet1982https://conductscience.org/library/papers/7166176PubMed
7,002,065Clotrimazole in rheumatoid arthritis.Ann Rheum Dis1980https://conductscience.org/library/papers/7002065PubMed
6,967,398An overview of the current status of levamisole in the treatment of rheumatic diseases.Drugs1980https://conductscience.org/library/papers/6967398PubMed
6,830,330Thymopoietin and levamisole in chronic granulomatous inflammation.Ann Rheum Dis1983https://conductscience.org/library/papers/6830330PubMed
6,711,389Prolonged treatment with D-penicillamine: effects on adjuvant arthritis in the rat.Agents Actions1984https://conductscience.org/library/papers/6711389PubMed
6,453,230Levamisole-induced lichenoid eruptions.J R Soc Med1980https://conductscience.org/library/papers/6453230PubMed
3,083,661Effects of d-penicillamine, levamisole and tiopronin on eicosanoid synthesis by rat gut tissue.Agents Actions1986https://conductscience.org/library/papers/3083661PubMed
2,668,158The stimulation of IL-2 production by anti-rheumatic drugs.Immunology1989https://conductscience.org/library/papers/2668158PubMed
1,085,681The effect of Levamisole on peripheral blood lymphocyte subpopulations in patients with rheumatoid arthritis and ankylosing spondylitis.Clin Exp Immunol1976https://conductscience.org/library/papers/1085681PubMed
970,290Pertussis vaccine oedema: an experimental model for the action of penicillamine-like drugs.Agents Actions1976https://conductscience.org/library/papers/970290PubMed
930,758The effect of drugs in established rabbit monoarticular arthritis.Agents Actions1977https://conductscience.org/library/papers/930758PubMed
890,415Levamisol-induced thrombocytopenia.Br Med J1977https://conductscience.org/library/papers/890415PubMed
849,643
Serum effects of mitogenic reactivity in subjects with systemic lupus erythematosus, rheumatoid arthritis and scleroderma. Technical considerations and lack of correlation with anti-lymphocyte antibodies.
Clin Exp Immunol1977https://conductscience.org/library/papers/849643PubMed

See all 45 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/55652

GET https://conductscience.org/api/papers/v1/55652/cited_by?page=2